IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 4, 2008
Insider Transaction Report
Form 4
Bexon Alice
V.P. Clinical Development
Transactions
- Award
Stock Option
2008-01-02+20,000→ 20,000 totalExercise: $13.28Exp: 2018-01-02→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in equal quarterly installments over four years beginning with the quarter ending April 2, 2008.